Abbonarsi

Correlation of the pediatric metabolic index with NAFLD or MAFLD diagnosis, and serum adipokine levels in children - 31/05/23

Doi : 10.1016/j.clinre.2023.102137 
Maria-Luisa Lazo-de-la-Vega-Monroy a, #, Monica-del-Carmen Preciado-Puga b, #, Yeniley Ruiz-Noa a, Marcia Salum-Zertuche b, Lorena-del-Rocio Ibarra-Reynoso a,
a Department of Medical Sciences, Health Sciences Division, University of Guanajuato Leon Campus, Mexico 
b Department of Medicine and Nutrition, Health Sciences Division, University of Guanajuato Leon Campus, Mexico 

Corresponding author: Lorena-del-Rocio Ibarra-Reynoso, University of Guanajuato, Department of Medical Sciences, Health Sciences Division, Leon Campus. 20 de enero 929. Obregón. León, Gto., CP 37320, México.University of GuanajuatoDepartment of Medical Sciences, Health Sciences Division, Leon Campus20 de enero 929. ObregónLeón, GtoCP37320México

Highlights

PMI correlated positively with NAFLD and MAFLD diagnoses.
Leptin and adiponectin levels correlate with the presence of MAFLD.
PMI is a potential marker of hepatic fat with or without metabolic dysfunction.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Introduction

Non-alcoholic fatty liver disease (NAFLD) is characterized by ectopic fat deposition in the liver. However, a recent classification of this condition, which also integrates the presence of coexisting metabolic disorders, termed Metabolic dysfunction Associated Fatty Liver Disease (MAFLD), has been proposed.

NAFLD is increasingly common in early childhood, partly due to the increase in metabolic disease in this age. Thus, studying hepatic steatosis in the metabolic context has become important in this population as well. However, NAFLD, and thus MAFLD, diagnosis in children is challenging by the lack of non-invasive diagnostic tools comparable to the gold standard of hepatic biopsy. Recent studies have reported that the Pediatric Metabolic Index (PMI) could be a marker of insulin resistance and abnormal liver enzymes, but its association with NAFLD, MAFLD, or altered adipokines in these conditions has not been reported. The aim of this study is to evaluate the correlation between PMI with the diagnosis of NAFLD or MAFLD, together with serum levels of leptin and adiponectin, in school-age children.

Methods

A cross sectional study was carried out in two hundred and twenty-three children without medical history of hypothyroidism, genetic, or chronic diseases. Anthropometry, liver ultrasound, and serum levels of lipids, leptin, and adiponectin were evaluated. The children were classified as having NAFLD or non-NAFLD, and a subgroup of MAFLD in the NAFLD group was analyzed. The PMI was calculated by the established formulas for age and gender.

Results

PMI correlated positively with the presence and severity of NAFLD (r = 0.62, p<0.001 and r = 0.79, p<0.001 respectively) and with the presence of MAFLD (r = 0.62; p<0.001). Also, this index correlated positively with serum leptin levels (r = 0.66; p<0.001) and negatively with serum adiponectin levels (r= -0.65; p<0.001). PMI showed to be a good predictor for diagnosing NAFLD in school-age children when performing a ROC curve analysis (AUROC=0.986, p< 0.0001).

Conclusion

PMI could be a useful tool for the early diagnosis of NAFLD or MAFLD in children. However, future studies are necessary to establish validated cut-off points for each population.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Metabolic-associated fatty liver disease, Non-alcoholic fatty liver disease, Pediatric metabolic index


Mappa


© 2023  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 47 - N° 6

Articolo 102137- Giugno 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • The “reverse vessel sign” mandating endoscopic hemostasis after cold snare removal of a large adherent clot in lower GI bleeding
  • Vincent Zimmer
| Articolo seguente Articolo seguente
  • The association of antibiotic exposure with new-onset inflammatory bowel disease: A systematic review and meta-analysis
  • Sophia Haroon Dar, Muhammad Talha Maniya, Nooraldin Merza, Adeena Musheer, Mariyam Zahid, Furqan Ahmed, Qazi Shurjeel, Sana Qazi, Aymen Ahmed, Hamza Shah, Adnan Zafar, Arsalan Zafar Iqbal, Shah Fahad Khan, Tehlil Rizwan, Rosario Ligresti

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.